Charles River Associates (CRA) Announces Vice President Promotions - Seite 2

Erik Himan has more than 15 years of experience applying economic and quantitative methods to problems in complex business litigation as a testifying expert and as a consultant. He specializes in the areas of business and asset valuation, appraisals and price disputes, assessing solvency in ability-to-pay and fraudulent conveyance claims, securities litigation, accounting issues, measurement of damages and the economic analysis of material adverse effects. He also consults on antitrust matters. Mr. Himan has been engaged in numerous matters by both the merging parties and the government agencies, including the Federal Trade Commission and the US Department of Justice, in the verification of merger efficiencies and synergies in horizontal mergers. He has worked across many industries, including retail, financial services, automotive, payment and credit cards, energy, real estate, health services, transportation, steel, and telecommunications, among others. Mr. Himan is a CFA Charterholder and a Certified Valuation Analyst (CVA) as recognized by the National Association of Certified Valuators and Analysts (NACVA).

Jennifer Johnson joined CRA with more than 12 years of life sciences consulting experience and is passionate about using data-driven approaches to help pharmaceutical clients compete in today’s increasingly value-based market. Prior to joining CRA in October 2019, she was a Principal at IQVIA and previously worked at AmerisourceBergen’s Xcenda and Lash Group companies. Ms. Johnson uses a mix of modalities to answer key business questions and has specific expertise integrating large data sets such as patient-level prescription and medical claims, distribution information, and formulary information to tease out patient, provider, and payer dynamics. She has advised multiple clients on launch and inline strategy across a number of therapeutic areas, including HIV and oncology. With a background in patient support program operations, helping manufacturers develop sustainable, optimized patient access solutions is core to Ms. Johnson’s work.

Michal Malkiewicz specializes in the application of economics, finance, statistics, and survey research methods to complex business and public policy questions, commercial disputes, and investigations. Mr. Malkiewicz has worked extensively analyzing issues in health care, life sciences, high-tech, and other industries. He has been retained as an expert in patent, copyright, and trademark infringement, false advertising, breach of contract, misappropriation of trade secrets, defamation, and unfair competition disputes. Mr. Malkiewicz’s experience also includes rate setting for standard essential patents and economic analysis in unfair import investigations. He has testified as an expert witness before US federal courts, international arbitration panels, and administrative law judges at the US International Trade Commission. Prior to consulting, Mr. Malkiewicz worked as a survey research professional and an economic research assistant to the Hon. Richard A. Posner.